Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Genestin
E. Genestin
Medicine
Insulin
Type 2 Diabetes Mellitus
Library science
Lanreotide
6
Papers
189
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Beginning insulin in people with type 2 diabetes mellitus in real life practice-1-year results of the 4-year CREDIT Study
2010
Philip Home
Bj Balkau
N Danchin
E. Genestin
Michel Marre
G Vespasiani
Ryuzo Kawamori
Nick Freemantle
Show All
Source
Cite
Save
Citations (3)
Risk factors for symptomatic hypoglycaemia in people with type 2 diabetes mellitus initiated on insulin therapy: evidence from the CREDIT study
2010
G Vespasiani
Nick Freemantle
Bj Balkau
N Danchin
E. Genestin
Michel Marre
Ryuzo Kawamori
Philip Home
Show All
Source
Cite
Save
Citations (2)
Insulin Initiation in People with Type 2 Diabetes Mellitus (T2DM) in Real Life Practice-1-Year (yr) Results of the 4-yr CREDIT Study
2010
Nick Freemantle
Bj Balkau
N Danchin
E. Genestin
Michel Marre
G Vespasiani
Ryuzo Kawamori
Philip Home
Show All
Source
Cite
Save
Citations (2)
Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
1996
Gut
Philippe Ruszniewski
Michel Ducreux
J.A. Chayvialle
Joëlle Blumberg
D. Cloarec
H. Michel
Raymond Jm
Jean-Louis Dupas
H. Gouerou
Raymond Jian
E. Genestin
P. Bernades
Philippe Rougier
Show All
Source
Cite
Save
Citations (180)
REGRESSION PARTIELLE D'UNE TUMEUR DESMOIDE APRES TRAITEMENT PROLONGE PAR LE LANREOTIDE
1995
Gastroenterologie Clinique Et Biologique
P.-R. Mannant
Philippe Beau
V. de Ledinghen
Thierry Barrioz
E. Genestin
Show All
Source
Cite
Save
Citations (2)
1